MicroRNA-451 protects against cardiomyocyte anoxia/reoxygenation injury by inhibiting high mobility group box 1 expression

Molecular Medicine Reports

Volumn 13, Issue 6, 2016, Pages 5335-5341

  Xie, Jing ^a   Hu, Xiaorong ^a   Yi, Chunfeng ^a   Hu, Gangying ^a   Zhou, Xiaoya ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Anoxia reoxygenation; Cardiomyocytes; High mobility group box 1 protein; MicroRNA 451

Indexed keywords

CASPASE 3; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 451; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; HBP1 PROTEIN, RAT; MIRN451 MICRORNA, RAT;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ANOXIA REOXYGENATION INJURY; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL DAMAGE; CELL HYPOXIA; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HEART MUSCLE INJURY; HEART PROTECTION; IN VITRO STUDY; LUCIFERASE ASSAY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HUMAN; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY;

ANIMALS; GENE EXPRESSION REGULATION; HEK293 CELLS; HMGB1 PROTEIN; HUMANS; MICRORNAS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RATS;

EID: 84966680745     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5192     Document Type: Article

References (33)

1. Guilbert JJ: The world health report 2002-reducing risks, promoting healthy life. Educ Health (Abingdon) 16: 230, 2003.
2. Becker LC and Ambrosio G: Myocardial consequences of reperfusion. Prog Cardiovasc Dis 30: 23-44, 1987.
3. Gottlieb RA and Engler RL: Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci 874: 412-426, 1999.
4. Zweier JL and Talukder MA: The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 70: 181-190, 2006.
5. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, et al: High-mobility Group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216-3226, 2008.
6. Hashimoto T, Ishii J, Kitagawa F, Yamada S, Hattori K, Okumura M, Naruse H, Motoyama S, Matsui S, Tanaka I, et al: Circulating high-mobility Group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis 221: 490-495, 2012.
7. Hu XR, Wang XH, Liu HF, Zhou WJ and Jiang H: High mobility Group box 1 protein: Possible pathogenic link to atrial fibrillation. Chin Med J (Engl) 125: 2346-2348, 2012.
8. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, et al: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201: 1135-1143, 2005.
9. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Eulalio A, Huntzinger E and Izaurralde E: Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14, 2008.
11. Perron MP and Provost P: Protein interactions and complexes in human microRNA biogenesis and function. Front Biosci 13: 2537-2547, 2008.
12. Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780, 2006.
13. Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ and Fan GC: MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119: 2357-2366, 2009.
14. Van Rooij E and Olson EN: MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376, 2007.
15. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J and Zhang C: Ischaemic preconditioning-regulated MIR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87: 431-439, 2010.
16. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z and Huang G: MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J 50: 377-387, 2009.
17. Ye Y, Hu Z, Lin Y, Zhang C and Perez-Polo JR: Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res 87: 535-544, 2010.
18. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, Jegga AG and Fan GC: Synergistic effects of the GATA-4-mediated MIR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 49: 841-850, 2010.
19. Agarwal V, Bell GW, Nam JW, Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, 2015.
20. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals (eds): Guide for the Care and Use of Laboratory Animals. National Academies Press (US), Washington (DC), 2011.
21. Hu X, Zhou X, He B, Xu C, Wu L, Cui B, Wen H, Lu Z and Jiang H: Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility Group box 1 protein in rats. Eur J Pharmacol 638: 84-89, 2010.
22. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
23. Xie J, Zhou X, Hu X and Jiang H: H2O2 evokes injury of cardiomyocytes through upregulating HMGB1. Hellenic J Cardiol 55: 101-106, 2014.
24. Bergamaschi A and Katzenellenbogen BS: Tamoxifen downregulation of MIR-451 increases 14-3-3 and promotes breast cancer cell survival and endocrine resistance. Oncogene 31: 39-47, 2012.
25. Lopotová T, Záčková M, Klamová H and Moravcová J: MicroRNA-451 in chronic myeloid leukemia: MIR-451-BCR-ABL regulatory loop? Leuk Res 35: 974-977, 2011.
26. Yu D, dos Santos CO, Zhao G, Jiang J, Amigo JD, Khandros E, Dore LC, Yao Y, D'Souza J, Zhang Z, et al: MIR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev 24: 1620-1633, 2010.
27. Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, Ren X and Fan GC: Loss of the MIR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 94: 379-390, 2012.
28. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR and Billiar TR: HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204: 2913-2923,2007.
29. Yang QW, Xiang J, Zhou Y, Zhong Q and Li JC: Targeting HMGB1/TLR4 signaling as a novel approach to treatment of cerebral ischemia. Front Biosci (Schol Ed) 2: 1081-1091,2010.
30. Yang Z, Deng Y, Su D, Tian J, Gao Y, He Z and Wang X: TLR4 as receptor for HMGB1-mediated acute lung injury after liver ischemia/reperfusion injury. Lab Invest 93: 792-800,2013.
31. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, et al: High mobility Group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 92: 565-570, 2000.
32. Sha Y, Zmijewski J, Xu Z and Abraham E: HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180: 2531-2537, 2008.
33. Xu H, Yao Y, Su Z, Yang Y, Kao R, Martin CM and Rui T: Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK. Am J Physiol Heart Circ Physiol 300: H913-921, 2011.